Antiplatelet Therapy is Associated with Stent Patency After Iliocaval Venous Stenting
- 17 August 2018
- journal article
- research article
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 41 (11) , 1691-1698
Abstract
To examine the effectiveness of antithrombotic medications to prevent venous stent malfunction for iliocaval occlusive disease.Keywords
This publication has 14 references indexed in Scilit:
- A risk scoring system to predict coronary stent thrombosisCurrent Medical Research and Opinion, 2017
- Endovascular management of chronic total occlusions of the inferior vena cava and iliac veinsJournal of Vascular Surgery: Venous and Lymphatic Disorders, 2017
- Endovascular Stent Placement for May–Thurner Syndrome in the Absence of Acute Deep Vein ThrombosisJournal of Vascular and Interventional Radiology, 2016
- Iliocaval Confluence Stenting for Chronic Venous ObstructionsCardioVascular and Interventional Radiology, 2015
- Endovascular Management of Nonmalignant Iliocaval Venous LesionsAnnals of Vascular Surgery, 2013
- Percutaneous recanalization of total occlusions of the iliac veinJournal of Vascular Surgery, 2009
- Endovascular Management of Chronic Disabling Ilio-caval Obstructive Lesions: Long-Term ResultsEuropean Journal of Vascular and Endovascular Surgery, 2009
- Factors associated with outcome after interventional treatment of symptomatic iliac vein compression syndromeJournal of Vascular Surgery, 2007
- Obstructive lesions of the inferior vena cava: Clinical features and endovenous treatmentJournal of Vascular Surgery, 2006
- Reporting standards in venous disease: An updateJournal of Vascular Surgery, 1995